Smartlens Secures $5.2M Bridge Round Led by Ambit Health Ventures
Growth StageVenture Capital

Smartlens Secures $5.2M Bridge Round Led by Ambit Health Ventures

Oct 14, 2025

Deal Summary

Smartlens, a clinical-stage ophthalmic technology company in Sunnyvale, closed a $5.2M bridge funding round led by Ambit Health Ventures with participation from Graphene Ventures, Boutique Venture Partners, Harvard Business School Alumni Angels GNY and a group of eye care providers. The proceeds will support advancement of its next-generation glaucoma management devices.

Comments

Want to join the conversation?

Loading comments...